Cargando…

An overview of efficacy and safety of ambroxol for the treatment of acute and chronic respiratory diseases with a special regard to children

Introduction: Ambroxol (2-amino-3,5-dibromo-N-[trans-4-hydroxycyclohexyl]benzylamine), an over-the-counter product, is a mucoactive agent and has been used widely to treat both acute and chronic respiratory diseases since 1978. This review aims to provide an overview of the clinical evidence availab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kantar, Ahmad, Klimek, Ludger, Cazan, Dorotheea, Sperl, Annette, Sent, Ulrike, Mesquita, Margarida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137760/ https://www.ncbi.nlm.nih.gov/pubmed/32269775 http://dx.doi.org/10.4081/mrm.2020.511

Ejemplares similares

Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan(®) Retard) Compared with Other Formulations in Healthy Volunteers
por: Ollier, Celine, et al.
Publicado: (2020)

Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations
por: Kardos, Peter, et al.
Publicado: (2018)

Study on the Efficacy and Safety of Ambroxol Combined with Methylprednisolone in Patients with Acute Lung Injury
por: Su, Weiwei, et al.
Publicado: (2021)

A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations
por: Klimek, Ludger, et al.
Publicado: (2014)

Ambroxol for the treatment of fibromyalgia: science or fiction?
por: Kern, Kai-Uwe, et al.
Publicado: (2017)

Value of ambroxol in the treatment of asthmatic bronchitis
por: Du, Xiaoxia, et al.
Publicado: (2020)

Polypharmacology of ambroxol in the treatment of COVID-19
por: Wang, Ziyuan, et al.
Publicado: (2023)

Use of Ambroxol as Therapy for Gaucher Disease
por: Zhan, Xia, et al.
Publicado: (2023)

Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis
por: Chenot, Jean-François, et al.
Publicado: (2014)

Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficulty
por: Zheng, Zeguang, et al.
Publicado: (2023)

Different ventilation modes combined with ambroxol in the treatment of respiratory distress syndrome in premature infants
por: Zhou, Bin, et al.
Publicado: (2017)

Efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distress syndrome
por: Xiang, Jiajun, et al.
Publicado: (2019)

Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
por: Bendikov-Bar, Inna, et al.
Publicado: (2013)

Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation
por: Takeda, Katsuyuki, et al.
Publicado: (2016)

Efficacy and safety of ambroxol hydrochloride in the treatment of secretory otitis media: a systematic review and meta-analysis
por: Zhou, Xufeng, et al.
Publicado: (2022)

Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016)

Ambroxol: utilidad en la enfermedad de menbrana hiliana
por: Reyes Salazar, Gonzálo
Publicado: (1995)

Preparation and Evaluation of Microencapsulated Fast Melt Tablets of Ambroxol Hydrochloride
por: Jacob, S., et al.
Publicado: (2009)

The protective effects of Ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats
por: Gao, Xiwen, et al.
Publicado: (2011)

Simultaneous UV Spectrophotometric Estimation of Ambroxol Hydrochloride and Levocetirizine Dihydrochloride
por: Prabhu, S. Lakshmana, et al.
Publicado: (2008)

Enhanced Controlled Transdermal Delivery of Ambroxol from the EVA Matrix
por: Cho, C. W., et al.
Publicado: (2012)

Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2
por: Alkotaji, Myasar
Publicado: (2020)

Ambroxol Treatment Suppresses the Proliferation of Chlamydia pneumoniae in Murine Lungs
por: Kókai, Dávid, et al.
Publicado: (2021)

Does Ambroxol alleviate kidney ischemia-reperfusion injury in rats?
por: Gültekin, Çağrı, et al.
Publicado: (2022)

Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
por: Narita, Aya, et al.
Publicado: (2016)

Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons
por: Magalhaes, J., et al.
Publicado: (2018)

Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate
por: Migdalska‐Richards, Anna, et al.
Publicado: (2017)

Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole
por: Li, Xiuyun, et al.
Publicado: (2017)

Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol
por: Heber, Sebastian, et al.
Publicado: (2022)

Mechanistic Insight into the Mode of Action of Acid β-Glucosidase Enhancer Ambroxol
por: Pantoom, Supansa, et al.
Publicado: (2022)

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Ambroxol Hard-Boiled Lozenges in Patients with Acute Pharyngitis
por: Sousa, Rita, et al.
Publicado: (2019)

Efficacy of high-dose ambroxol for paraquat poisoning: A meta-analysis of randomized controlled trials
por: Wang, Junwu, et al.
Publicado: (2020)

Meta-analysis of the efficacy of budesonide and ambroxol hydrochloride inhalation in children with pneumonia and their effects on inflammatory response
por: Shen, Huanan, et al.
Publicado: (2023)

Biodegradable Chitosan-Based Ambroxol Hydrochloride Microspheres: Effect of Cross-Linking Agents
por: Gangurde, HH, et al.
Publicado: (2011)

Uso de ambroxol vs ventilación con enfermedad de membrana hialina
por: Ramírez Pérez, Manuel Adhiel
Publicado: (1999)

Isolation, Identification, and Characterization of One Degradation Product in Ambroxol by HPLC-Hyphenated Techniques
por: Thummala, Veera Raghava Raju, et al.
Publicado: (2014)

Ambroxol hydrochloride in the management of idiopathic pulmonary fibrosis: Clinical trials are the need of the hour
por: Gupta, P. R.
Publicado: (2014)

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
por: McNeill, Alisdair, et al.
Publicado: (2014)

Effect of ambroxol on the concentration of cefotaxime in the bronchoalveolar lavage fluid of rats with pulmonary fibrosis
por: CHEN, FENG, et al.
Publicado: (2015)

Topical ambroxol for the treatment of neuropathic pain: An initial clinical observation. English version
por: Kern, K.-U., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3sfkrmvtu525oo8eebh1ci67aa